The Present Condition of Sickle Cell Disease: An Overview of Stem Cell Transplantation as a Cure

Treatment of sickle cell disease (SCD) remains largely palliative. While it can enhance living standards, persons having SCD still suffer from extreme sickling crises, end-organ destruction, and reduced life expectancy. Increasing research has resulted in the recognition and advancement of stem cell...

Full description

Saved in:
Bibliographic Details
Published in:Pharmaceutical fronts 2023-06, Vol.5 (2), p.e57-e63
Main Authors: Hussain, Md. Sadique, Chaturvedi, Varunesh
Format: Article
Language:English
Subjects:
cord blood
gene therapy
haploidentical
stem cell transplantation
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Treatment of sickle cell disease (SCD) remains largely palliative. While it can enhance living standards, persons having SCD still suffer from extreme sickling crises, end-organ destruction, and reduced life expectancy. Increasing research has resulted in the recognition and advancement of stem cell transplantation and gene therapy as possible solutions for SCDs. However, there have been various factors that have hindered their clinical application. The more advantageous of the two, stem cell transplantation, is constrained by a small donor pool, transplant difficulties, and eligibility requirements. The current article reviewed the literature on SCDs, current treatment options, and more particularly the progress of stem cell transplants. It outlined various challenges of stem cell transplant and proposed ways to increase the donor pool using alternative strategies and modifications of regimen conditioning with minimal transplant-related toxicities and associated complications.
ISSN:2628-5088
2628-5096
DOI:10.1055/s-0043-1768918